FGF‐8 is involved in bone metastasis of prostate cancer
Open Access
- 24 April 2008
- journal article
- fast track
- Published by Wiley in International Journal of Cancer
- Vol. 123 (1), 22-31
- https://doi.org/10.1002/ijc.23422
Abstract
Prostate cancer is the most common malignancy of men in Western countries. Patients with advanced prostate cancer suffer from incurable bone metastases. Recent data indicate that interactions between prostate cancer cells, osteoblasts, osteoclasts and the bone matrix are essential in the formation of bone metastases. FGF‐8 is widely overexpressed in prostate cancer. Recently, FGF‐8 has been found to affect both osteoblast and osteoclast differentiation. The aim of this study was to examine the role of FGF‐8 in bone metastasis of prostate cancer. Immunohistochemistry was used to analyse FGF‐8 expression in clinical samples of prostate cancer bone metastases. The functional significance of FGF‐8 in growth of bone metastasis and formation of bone lesions was verified by using intratibial inoculations of FGF‐8 or mock transfected PC‐3 prostate cancer cells in nude mice. Intratibial tumors and bone lesions were analysed with X‐ray, micro‐CT and detailed histomorphometry using image analysis software and with immunostaining for osteocalcin and cathepsin K. Immunohistochemical analysis of tissue microarray of bone metastases of human prostate cancer showed that 76% of human bone metastasis samples (n = 25 from 11 patients) were positive for FGF‐8. FGF‐8 increased the growth of intratibial tumors and local formation of lytic and sclerotic lesions of bone. These results demonstrate that FGF‐8 is expressed at a high frequency in bone metastases of human prostate cancer and that expression of FGF‐8 in PC‐3 prostate cancer cells increases their growth as intratibial tumors and modulates formation of bone lesions in an in vivo model of prostate cancer bone metastasis.Keywords
This publication has 41 references indexed in Scilit:
- Interleukin-8 Is a Molecular Determinant of Androgen Independence and Progression in Prostate CancerCancer Research, 2007
- Secondary prostatic adenocarcinoma: A cytopathological study of 50 casesDiagnostic Cytopathology, 2007
- Loss of Sef (similar expression to FGF) expression is associated with high grade and metastatic prostate cancerOncogene, 2006
- Prostate cancer mediates osteoclastogenesis through two different pathwaysCancer Letters, 2005
- A Neutralizing Anti–Fibroblast Growth Factor 8 Monoclonal Antibody Shows Potent Antitumor Activity against Androgen-Dependent Mouse Mammary Tumors In vivoClinical Cancer Research, 2005
- The role of the stromal microenvironment in prostate cancerSeminars in Cancer Biology, 2005
- Prostate cancer metastases to bone: Pathophysiology, pain management, and the promise of targeted therapyEuropean Journal Of Cancer, 2005
- Osteoblasts in prostate cancer metastasis to boneNature Reviews Cancer, 2005
- Fibroblast growth factor 17 is over‐expressed in human prostate cancerThe Journal of Pathology, 2004
- Fibroblast Growth Factors and Their Receptors in Urological Cancers: Basic Research and Clinical ImplicationsEuropean Urology, 2003